Glycosphingolipids as differentiation-dependent, tumor-associated markers and as regulators of cell proliferation
- 1 October 1984
- journal article
- review article
- Published by Elsevier in Trends in Biochemical Sciences
- Vol. 9 (10), 453-459
- https://doi.org/10.1016/0968-0004(84)90156-7
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Localization and alteration of mono-, di-, and trifucosyl alpha 1----3 type 2 chain structures during human embryogenesis and in human cancer.The Journal of Experimental Medicine, 1984
- Enzymic basis for the modulation of cell-surface carbohydrates in lectin-resistant melanoma cellsBiochemical Society Transactions, 1983
- Human cancer-associated gangliosides defined by a monoclonal antibody (IB9) directed to sialosylα2→6galactosyl residue: A preliminary noteBiochemical and Biophysical Research Communications, 1983
- A Glycolipid Antigen Associated with Burkitt Lymphoma Defined by a Monoclonal AntibodyScience, 1983
- GD3, a prominent ganglioside of human melanoma. Detection and characterisation by mouse monoclonal antibody.The Journal of Experimental Medicine, 1982
- Stage-specific embryonic antigen involves αl→ 3 fucosylated type 2 blood group chainsNature, 1981
- A Monosialoganglioside Is a Monoclonal Antibody-Defined Antigen of Colon CarcinomaScience, 1981
- Therapy of Mouse Lymphoma with Monoclonal Antibodies to Glycolipid: Selection of Low Antigenic Variants in VivoScience, 1981
- Tumor‐Associated Glycolipid Antigens and Modified Blood Group AntigensScandinavian Journal of Immunology, 1978
- Lacto-N-neotetraosylceramide (“paragloboside”) as a possible tumor) associated surface antigen of hamster NILpy tumorBiochemical and Biophysical Research Communications, 1976